Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00018863 · ClinicalTrials.gov registry record · Phase 3
Treatment of Attention Deficit Hyperactivity Disorder in Preschool-Age Children (PATS)
A Phase 3 study, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- Phase 3
- Development phase
- 165
- Enrollment target
NCT00018863 is a Phase 3 study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 165 participants.
The verdict
NCT00018863, a Phase 3 study, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 165 participants
- Enrollment target
Study Summary
This research focuses on the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in very young children. The medication being used is methylphenidate (Ritalin); it is being studied to determine its safety and how well it works to treat ADHD in preschool-age children (3-5.5 year olds).
Interventions
- DRUG Methylphenidate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 165 participants |
| Start Date | 2001-04-01 |
| Est. Completion | 2006-11-30 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00018863
The ClinicalTrials.gov registry entry for NCT00018863 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 165 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Methylphenidate is the first listed.
NCT00018863 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00018863 about?
NCT00018863 is a clinical study titled "Treatment of Attention Deficit Hyperactivity Disorder in Preschool-Age Children (PATS)". This research focuses on the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in very young children. The medication being used is methylphenidate (Ritalin); it is being studied to determine its safety and how well it works to treat ADHD in preschool-age children (3-5.5 year olds).
What is the current status of trial NCT00018863?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 165 participants. The study started on 2001-04-01. Estimated completion is 2006-11-30.
What interventions are being tested in trial NCT00018863?
The interventions under investigation include: Methylphenidate (DRUG).
Who is sponsoring clinical trial NCT00018863?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.